معرفی
Dr Emma Louise Sweeney is a Senior Research Fellow at the University of Queensland’s Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences. She leads a translational research programme that bridges molecular microbiology and clinical diagnostics to combat antimicrobial resistance in sexually transmitted infections and perinatal pathogens.
Education
- Bachelor of Applied Science (QUT)
- Bachelor (Honours) of Applied Science (QUT)
- Doctor of Philosophy (QUT)
Research Focus
Her laboratory investigates Mycoplasma genitalium, Neisseria gonorrhoeae, Ureaplasma spp. and cytomegalovirus with the overarching goal of developing resistance-guided, precision diagnostics that inform individualised therapy. Key themes include:
- Molecular mechanisms of macrolide and fluoroquinolone resistance
- Next-generation point-of-care assays for STI clinics
- Placental and neonatal microbiome interactions influencing preterm birth
- CMV antiviral resistance in immunocompromised children
Publication Trends
Between 2015 and 2025 Emma has published 48 works spanning high-impact journals such as The Lancet Microbe, Nature Microbiology, Clinical Infectious Diseases, Journal of Clinical Microbiology and Journal of Infectious Diseases. Recent outputs emphasise systematic reviews of global AMR trends, in-vivo murine models of genital infection, and real-world evaluation of commercial molecular assays.
Funding & Grants
- 2023–2025 NHMRC Ideas Grant – Enhanced HHV-6 diagnostics in children
- 2020–2023 Children’s Hospital Foundation – CMV resistance-guided therapy in HSCT
- 2019–2022 ASHM Grant – Precision public health for syphilis in Queensland
- 2018–2020 Pathology Queensland – M. genitalium AMR diagnostics
Supervision & Mentoring
Emma is currently available for HDR supervision and mentors three active PhD projects. She has successfully graduated one PhD student (2025) whose thesis developed an integrated molecular pathway for CMV management in paediatric transplant recipients.
